Germline mutations of the p53 gene in children with malignant solid tumors

Journal of Experimental and Clinical Cancer Research

Volumn 17, Issue 4, 1998, Pages 497-502

  Ayan, I ^a   Luca, J W ^b   Jaffe, N ^b   Yazici, H ^a   Ekmekcioglu S ^a   Hansen, M F ^c  

^a ISTANBUL UNIVERSITY   (Turkey)

^b UNIVERSITY OF TEXAS   (United States)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Childhood malignant tumors; P53 germline mutation; Rhabdomyosarcoma

Indexed keywords

DNA; PROTEIN P53;

ADOLESCENT; ARTICLE; BRAIN TUMOR; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; DNA SEQUENCE; EWING SARCOMA; GENE MUTATION; HEREDITY; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; NEPHROBLASTOMA; NEUROBLASTOMA; NONHODGKIN LYMPHOMA; OSTEOSARCOMA; PRIORITY JOURNAL; RHABDOMYOSARCOMA; SINGLE STRAND CONFORMATION POLYMORPHISM; SOLID TUMOR;

CHILD; CHILD, PRESCHOOL; DNA, NEOPLASM; EXONS; GERM-LINE MUTATION; HUMANS; NEOPLASMS; PEDIGREE; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SEQUENCE ANALYSIS, DNA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032447361     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Levine A.J.: The p53 tumor-suppressor gene. N. Engl. J. Med. 326: 1350-1352, 1992.
2. Levine A.J., Momand J., Finlay C.A.: The p53 tumour suppressor gene. Nature 351: 453-456, 1991.
3. Hollstein M., Sindransky D., Vogelstein B., Harris C.C.: P53 mutations in human cancers. Science 253: 49-53, 1991.
4. Hollstein M., Shomer B., Greenblatt M., Soussi T., Hoving E., Montesano R. et al.: Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation. Nucleic Acid. Res. 24: 141-146, 1996.
5. Hollstein M., Rice K., Greenblatt M.S., Soussi T., Fuchs R., Sorlie T. et al.: Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic acid Res. 22: 3551-3555, 1994.
6. Malklin D., Li F.P., Strong L.C., Fraumeni J.F.J., Nelson C.E., Kim D.H. et al.: Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasmas. Science 250: 1233-1238, 1990.
7. Malkin D., Jolly K.W., Barbier N., Look A.T., Friend S.H., Gebhardt M.C. et al.: Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasmas. N. Engl. J. Med. 326: 1309-1315, 1992.
8. Srivastava S., Zou Z.Q., Pirollo K., Blattner W. Chang E.H.: Germ-line transmission of a mutated p53 gene in a cancer prone family with Li-Fraumeni syndrome. Nature 348: 747-749, 1990.
9. Srivastava S., Wang S., Tong Y.A., Pirollo K., Chang E.H.: Several mutant p53 proteins detected in cancer-prone families with Li-Fraumeni syndrome exhibit transdominant effects on the biochemical properties of the wild-type p53. Oncogene 8: 2449-2456, 1993.
10. McIntryre J.F., Smith-Sorensen B., Friend S.H., Kassell J., Borresen A.L., Yan Y.X. et al.: Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma. J. Clin. Oncol. 12: 925-930, 1994.
11. Toguchida J., Yamaguchi T., Dayton S.H., Beauchamp R.L., Herrera G.E., Ishizaki K. et al.: Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma. N. Engl. J. Med. 326: 1301-1308, 1992.
12. Frebourg T., Friend S.H.: Cancer risks from germline p53 mutations. J. Clin. Invest. 90: 1637-1641, 1992.
13. Santibanez-Koref M.F., Birch J.M., Hartley A.L., Jones P.H., Craft A.W., Eden T. et al.: P53 germline mutations in Li-Fraumeni syndrome. Lancet 338: 1490-1491, 1991.
14. Eeles R.A., Warren W., Knee G., Bartek J., Averill D., Stratton M.R. et al.: Constitutional mutation in exon 8 of the p53 gene in a patient with multiple primary tumours: molecular and immunohistochemical findings. Oncogene 8: 1269-1276, 1993.
15. Felix C.A., Strauss E.A., D'Amico D., Tsokos M., Winter S., Mitsudomi T. et al.: A novel germline p53 splicing mutation in a pediatric patient with a second malignant neoplasm. Oncogene 8: 1203-1210, 1993.
16. Gutierrez M.I., Bhatia K.G., Barreiro C., Spangler G., Schvartzmann E., Muriel F.S. et al.: A de novo p53 germline mutation affecting codon 151 in a six year old child with multiple tumors. Hum. Molec. Genet. 3: 2247-2248, 1994.
17. Iavarone A., Matthay K.K., Steinkirchner T.M., Israel M.A.: Germ-line and somatic p53 gene mutations in multifocal osteogenic sarcoma. Proc. Natl. Acad. Sci. (USA) 89: 4207-4209, 1992.
18. Diller L., Sexsmith E., Gottlieb A., Li F.P., Malkin D.: Germline p53 mutations are frequently detected in young children with rhabdomyosarcoma. J. Clin. Invest. 95: 1606-1611, 1995.
19. Wagner J., Portwine C., Rabin K., Leclerc J.M., Narod S.A., Malkin D.: High frequency of germline p53 mutations in childhood adrenocortical cancer. J. Natl. Cancer Inst. 86: 1707-1710, 1994.
20. Grayson G.H., Moore S., Schneider B.G., Saldivar V., Hensel C.H.: Novel germline mutation of the p53 tumor suppressor gene in a child with incidentally discovered adrenal cortical carcinoma. Am. J. Pediatr. Hematol.-Oncol. 16: 341-347, 1994.
21. Krytsis A.P., Bondy M.L., Xiao M., Berman E.L., Cunningham J.E., Lee P.S. et al.: Germline p53 mutations in subsets of glioma patientes. J. Natl. Cancer Inst. 86: 344-349, 1994.
22. Chen P., Iavarone A., Fick J., Edwards M., Prados M., Israel M.A.: Constitutional p53 mutations associated with brain tumors in young adults. Cancer Genet. Cytogenet. 82: 106-115, 1995.
23. Sidransky D., Tokino T., Helzlsouer K., Zehnbauer B., Rausch G., Shelton B. et al.: Inherited p53 gene mutations in breast cancer. Cancer Res. 52: 2984-2986, 1992.
24. Birch J.M.: Germline mutations in the p53 tumour suppressor gene: scientific, clinical and ethical challenges. Br. J. Cancer 66: 424-426, 1992.
25. Eeles R.A.: Predictive testing for germline mutations in the p53 gene: are all the questions answered? Eur. J. Cancer 29A: 1361-1365, 1993.
26. Cavenee W.K., Dryja T.P., Phillips R.A., Benedit W.F., Godnout R., Gallie B.L. et al.: Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 305: 779-784, 1983.
27. Hansen M.F., Cavenee W.K.: Genetics of cancer predisposition. Cancer Res. 47: 5518-2527, 1987.
28. Li F.P., Correa P., Fraumeni J.F.: Testing for germ line mutations in cancer families. Cancer Epidemiol. Biomarkers Prevention 1: 91-94, 1991.
29. Miller S.A., Dykes D.D., Polesky H.F.: A simple salting out procedure of extracting DNA from human nucleated cells. Nucleic Acid Res. 16: 1215, 1988.
30. Mashiyama S., Murakami Y., Yoshimoto T., Sekyya T., Hayashi K.: Detection of p53 gene mutations in human brain tumors by single strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene 6: 1313-1318, 1991.
31. Orita M., Iwahana H., Kanazawa H., Hayashi K., Sekiya T.: Detection of polymorphisms of human DNA gel electrophoresis as single strand conformation polymorphisms. Proc. Natl. Acad. Sci. (USA) 86: 2766-2770, 1989.
32. Orita M., Suzuki Y., Sekiya T., Hayashi K.: Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5: 874-879, 1989.
33. Brugieres L., Gardes M., Moutou C., Chompret A., Meresse V., Martin A. et al.: Screening for germ line p53 mutations in children with malignant tumors and a family history of cancer. Cancer Res. 53: 452-455, 1993.
34. Birch J.M., Hartley A.L., Tricker K.J., Prosser J., Condie A., Kelsey A.M. et al.: Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res. 54: 1298-1304, 1994.
35. MacGeoch C., Turner G., Bobrow L.G., Barnes D.M., Bishop D.T., Spurr N.K.: Heterogeneity in Li-Fraumeni families: p53 mutation analysis and immunohistochemical staining. J. Med. Genet. 32: 186-190, 1995.